NA-Selank-Amidate: A Tracking Guide for the Long-Acting Selank Variant

NA-Selank-amidate is a chemically stabilised version of Selank, the anxiolytic peptide derived from the immune fragment tuftsin. The same two modifications used on the Semax variant - an acetyl group and a terminal amide - slow its breakdown, so it is reported to last longer and feel more pronounced than plain Selank.

It sits in the same "calm focus" niche as Selank, with the same honest limitation: clinical evidence is thin, and the amidated variant has even less public human safety data.

What people use it for

• Taking the edge off anxiety and stress without sedation
• A steadier focus, especially when anxiety is the thing breaking concentration
• Some users pair it with the Semax variant for a focus-plus-calm combination

What is different from plain Selank

• Longer duration, fewer doses needed
• Often reported as subjectively stronger
• Even less independent human data than standard Selank

Typical protocol shape (as reported)

• Intranasal, one or two doses per day
• Smaller per-dose amounts given the increased potency reports
• Used intermittently, often on high-stress days, rather than continuously

What to track daily

• Dose, drops or sprays, time
• Anxiety and stress (0-10)
• Focus and ability to start tasks
• Mood and irritability
• Sedation or flatness, which is the failure mode to watch
• Sleep and nasal irritation

What to track weekly

• A validated anxiety scale for an objective trend
• Whether the calm is helping function or just blunting affect
• Side-effect tally

Realistic expectations

• Effects are usually gentle and same-day, not a switch being flipped
• The line between "calmer" and "flatter" is individual; tracking mood and motivation catches it
• Clinical evidence remains limited, so treat conclusions as personal, not general

Common mistakes

• Overdosing because the amidate is stronger than plain Selank
• Confusing emotional blunting with genuine anxiety relief
• Continuous daily use when intermittent use was the goal
• No anxiety scale, so the record is mood-dependent memory

A tracking template

• Week 0: baseline anxiety scale and daily logs, no compound
• Weeks 1-3: protocol on stressful days, daily logs plus weekly scale
• Week 4: off, to judge durability and dependence

Safety notes

Human safety data is limited, more so for the amidated variant. The main reported issues are nasal irritation and, occasionally, unwanted sedation or flat mood. Anyone with a diagnosed anxiety disorder should be working with a clinician rather than self-medicating with a research peptide.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.